Use of double marking with retroviral vectors to determine rate of reconstitution of untreated and cytokine expanded CD34+ selected marrow cells in patients undergoing autologous bone marrow transplantation

Human Gene Therapy

Volumn 7, Issue 5, 1996, Pages 655-667

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6; STEM CELL FACTOR;

ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; BONE MARROW RESCUE; CHILDHOOD CANCER; CLINICAL PROTOCOL; CLINICAL TRIAL; EXPRESSION VECTOR; HEMATOPOIESIS; HUMAN; MARKER GENE; RETROVIRUS;

ANTIGENS, CD34; BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL PROTOCOLS; CYTOKINES; GENETIC MARKERS; GENETIC VECTORS; HUMANS; NEOPLASMS; RETROVIRIDAE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029928276     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.5-655     Document Type: Article

References (14)

1. Spitzer G, Velasquez W, Dunphy FR, Spencer V: Autologous bone marrow transplantation in solid tumors. Curr Opin Oncol 4:272-278, 1992.
2. Horowitz ME, Kinsella TJ, Wexler LH, Belasco J, Triche T, Tsokos M, Steinberg SM, McClure L, Longo DL, Steis RG et al: Total-body-irradiation and autologous bone marrow transplant in the treatment of high risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918, 1993.
3. Vose JM, Armitage JO: Role of autologous bone marrow transplantation in non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 7:577-590, 1993.
4. Jones RJ: Autologous bone marrow transplantation. Curr Opin Oncol 5:270-275, 1993.
5. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN: Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342:1134-1137, 1993.
6. Peters WP, Ross M, Vredenburgh J, Hussein A, Meisenberg B, Gilbert C, Petros WP, Kurtzberg J: Role of cytokines in autologous bone marrow transplantation. Hematol Oncol Clin North Am 7:737-747, 1993.
7. Kessinger A: Utilization of peripheral blood stem cells in autotransplantation. Hematol Oncol Clin North Am 7:535-545, 1993.
8. Naparstek E, Hardan Y, Ben-Shahar M, Nagler A, Or R, Muncuoglu M, Weiss L, Samuel S, Slavin S: Enhanced marrow recovery by short preincubation of marrow allografts with human recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor. Blood 80:1673-1678, 1992.
9. Dunbar CE, Nienhuis AW, Stewart FM, Quesenberry P, O'Shaughnessy J, Cowan K, Cottler-Fox M, Leitman S, Goodman S, Sorrentino BP, McDonagh K, Young NS, Donahue R, Bodine D, Cassell A: Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hemopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Hum Gene Ther 4:205-222, 1993.
10. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717-1722, 1991.
11. Shpall EJ, Jones RB, Bearman SI, Franklin WA, Archer PG, Curiel T, Bitter M, Claman HN, Stemmer SM, Purdy M, Myers SE, Hami L, Taffs S, Heimfeld S, Hallagan J, Berenson RJ: Transplantation of fnriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. Journal of Clinical Oncology 12:28-36, 1994.
12. Haylock DN, To LB, Dowse TL, Juttner CA, Simmons PJ: Ex vivo expansion and maturation of peripheral blood Cd34+ cells into the myeloid lineage. Blood 80:1405-1412, 1992.
13. Brugger W, Mocklin W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, Interleukin-1 beta (IL1-beta), IL-6, IL-3, interferon-gamma and erythropoietin. Blood 81:2579-2584, 1993.
14. Koller MR, Emerson SG, Palsson BO: Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378-384, 1993.